- Papers in database
- 22
- Years active
- 2007 – 2023
- Health outcomes studied
- 3
Health Outcomes Studied
Papers (22)
- 2023Orally Administered Bifidobacterium adolescentis Diminishes Serum Glutamate Concentration in Mice10.1128/spectrum.05063-22
- 2020Bifidobacterium adolescentis as a key member of the human gut microbiota in the production of GABA10.1038/s41598-020-70986-z
- 2020Revisiting the Metabolic Capabilities of Bifidobacterium longum susbp. longum and Bifidobacterium longum subsp. infantis from a Glycoside Hydrolase Perspective10.3390/microorganisms8050723
- 2020Bifidobacteriumlongum subsp. infantis CECT7210 (B. infantis IM-1®) Displays In Vitro Activity against Some Intestinal Pathogens10.3390/nu12113259
- 2017Bifidobacteria and Their Molecular Communication with the Immune System10.3389/fmicb.2017.02345
- 2017Chemical and biological properties of the novel exopolysaccharide produced by a probiotic strain of Bifidobacterium longum.10.1016/j.carbpol.2017.07.039
- 2017In vitro fermentation of different fructo-oligosaccharides by Bifidobacterium strains for the selection of synbiotic combinations.10.1016/j.ijfoodmicro.2016.11.011
- 2017Bifidobacteria and Their Health-Promoting Effects.10.1128/microbiolspec.BAD-0010-2016
- 2016Effect of Bifidobacterium upon Clostridium difficile Growth and Toxicity When Co-cultured in Different Prebiotic Substrates10.3389/fmicb.2016.00738
- 2016Effect of a Ropy Exopolysaccharide-Producing Bifidobacterium animalis subsp. lactis Strain Orally Administered on DSS-Induced Colitis Mice Model10.3389/fmicb.2016.00868
- 2015Probiotic and technological properties of Lactobacillus spp. strains from the human stomach in the search for potential candidates against gastric microbial dysbiosis10.3389/fmicb.2014.00766
- 2014Kefir fermented milk and kefiran promote growth of Bifidobacterium bifidum PRL2010 and modulate its gene expression.10.1016/j.ijfoodmicro.2014.02.024
- 2014Exopolysaccharide-producing Bifidobacterium animalis subsp. lactis strains and their polymers elicit different responses on immune cells from blood and gut associated lymphoid tissue.10.1016/j.anaerobe.2014.01.003
- 2013Evaluation of adhesion properties and antibacterial activities of the infant gut commensal Bifidobacterium bifidum PRL2010.10.1016/j.anaerobe.2013.03.003
- 2013Interactions between Bifidobacterium and Bacteroides Species in Cofermentations Are Affected by Carbon Sources, Including Exopolysaccharides Produced by Bifidobacteria10.1128/AEM.02545-13
- 2012Characterization of exopolysaccharides produced by Bifidobacterium longum NB667 and its cholate-resistant derivative strain IPLA B667dCo.10.1021/jf204034n
- 2012Complete Genome Sequence of Streptococcus salivarius PS4, a Strain Isolated from Human Milk10.1128/JB.00896-12
- 2011Technological characterization and survival of the exopolysaccharide-producing strain Lactobacillus delbrueckii subsp. lactis 193 and its bile-resistant derivative 193+ in simulated gastric and intestinal juices.10.1017/S0022029911000355
- 2011Safety and intestinal microbiota modulation by the exopolysaccharide-producing strains Bifidobacterium animalis IPLA R1 and Bifidobacterium longum IPLA E44 orally administered to Wistar rats.10.1016/j.ijfoodmicro.2010.10.016
- 2010Inside the adaptation process of Lactobacillus delbrueckii subsp. lactis to bile.10.1016/j.ijfoodmicro.2010.06.013
- 2009Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures.10.1016/j.ijfoodmicro.2009.08.017
- 2007Cell envelope changes in Bifidobacterium animalis ssp. lactis as a response to bile.10.1111/J.1574-6968.2007.00854.X